Detalles de la búsqueda
1.
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.
Diabetes Obes Metab
; 2024 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38764356
2.
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study.
Front Pharmacol
; 15: 1358573, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601470
3.
Progressive Thymic Hyperplasia With Graves' Disease: A Case Report.
Cureus
; 15(8): e43950, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37746349
4.
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication.
Diab Vasc Dis Res
; 20(6): 14791641231222837, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096503
Resultados
1 -
4
de 4
1
Próxima >
>>